ÂÜÀòÂÒÂ×

Thomas Dalle, PMP, has a diverse work experience spanning various industries. Thomas currently serves as a Project Manager for Corporate Affairs at Inotrem, a clinical-stage biotech company focused on innate immunity. In this role, they structure and coordinates financing projects and manages relations with potential investors and partners.

Prior to their current position, Dalle worked at Groupe Roullier, an international family group specializing in nutrition. As the Strategic Project Manager for the Supervisory Board, they provided consulting services and produced analyses for strategic business development opportunities. Dalle also played a pivotal role in developing and launching two innovative biotech product ranges for agriculture. As part of this, they managed a cross-functional team in 15 countries and completed the projects 50% faster than other company developments.

Before joining Groupe Roullier, Dalle worked as a Senior Financial Analyst in the Group Finance Department of the same company. Thomas was responsible for securing the sales cycle of subsidiaries and implemented several projects, including a scoring tool for assessing agriculture clients, a credit reporting project to visualize subsidiaries at risk, and risk management tools for CFOs and credit managers. Dalle also audited credit risk exposure in subsidiaries and negotiated deals with insurers to promote business development.

Earlier in their career, Dalle worked as a Senior Financial Auditor at PwC and held analyst positions at Goldman Sachs in derivatives sales and equity research for oil & gas. Thomas also worked as an Analyst in Investor Relations at Total.

Overall, Dalle has demonstrated their project management skills, financial expertise, and strategic thinking throughout their career.

Thomas Dalle, PMP, has a diverse education history. In 2011, they completed their Master in Management, specifically the 'Grande Ecole' program, at ESCP Business School, with a focus on finance and general studies. Thomas further expanded their knowledge in 2021 by pursuing The Science and Business of Biotechnology course offered by Andrew Lo and Harvey Lodish at the prestigious Massachusetts Institute of Technology. Additionally, in the same year, they took courses from the Master in Biopharmaceutical Management program at ESCP Business School. Thomas also engaged in a management exchange program at the Indian Institute of Management Bangalore, where they participated in the PGP Program. As further evidence of their commitment to professional development, Thomas obtained their Project Management Professional (PMP)® certification from the Project Management Institute in October 2019.